PAHC FY 2019 Earnings Report — Phibro Animal Health Corporation Revenue & Financial Results | Market Cap Arena

Phibro Animal Health CorporationPAHC

FY 2019 Earnings

Reported August 27, 2019

Quarter Comparison

Revenue

Operating Income

Gross Margin

Net Margin

EPS (Diluted)

Free Cash Flow

Metric	FY 2019	Prior Q	FY 2018	QoQ Change	YoY Change
Revenue	$828M	—	$820M	—	1.0%
Op. Income	$73M	—	$99M	—	-25.9%
Gross Margin	32.0%	—	32.5%	—	-0.6pp
Net Margin	6.6%	—	7.9%	—	-1.3pp
EPS (Diluted)	$1.35	—	$1.61	—	-16.1%
Free Cash Flow	$17M	—	$51M	—	-66.4%

Revenue Flow

Item	Amount
REVENUE	$828M
Cost of Revenue	$563M
GROSS PROFIT	$265M
R&D Expenses	$12M
Selling & Marketing	$0
General & Administrative	$0
SG&A Expenses	$181M
Other Expenses	$0
Operating Expenses	$181M
Cost & Expenses	$745M
OPERATING INCOME	$73M
Interest Income	$2M
Interest Expense	$14M
Other Income/Expenses	-$12M
INCOME BEFORE TAX	$72M
Income Tax Expense	$17M
Net Income from Continuing Ops	$55M
Net Income from Discontinued Ops	$0
Other Adjustments	$0
NET INCOME	$55M
Net Income Deductions	$0
BOTTOM LINE NET INCOME	$55M
D&A	$28M
EBIT	$85M
EBITDA	$113M
EPS	$1
EPS Diluted	$1

Income Statement

Item	Amount
REVENUE	$828M
Cost of Revenue	$563M
GROSS PROFIT	$265M
R&D Expenses	$12M
Selling & Marketing	$0
General & Administrative	$0
SG&A Expenses	$181M
Other Expenses	$0
Operating Expenses	$181M
Cost & Expenses	$745M
OPERATING INCOME	$73M
Interest Income	$2M
Interest Expense	$14M
Other Income/Expenses	-$12M
INCOME BEFORE TAX	$72M
Income Tax Expense	$17M
Net Income from Continuing Ops	$55M
Net Income from Discontinued Ops	$0
Other Adjustments	$0
NET INCOME	$55M
Net Income Deductions	$0
BOTTOM LINE NET INCOME	$55M
D&A	$28M
EBIT	$85M
EBITDA	$113M
EPS	$1
EPS Diluted	$1

Cash Flow Statement

Item	Amount
Net Income	$55M
Depreciation & Amortization	$28M
Stock-Based Compensation	$2M
Deferred Income Tax	-$105.0K
Other Non-Cash Items	-$1M
Change in Working Capital	-$36M
OPERATING CASH FLOW	$47M
Capital Expenditure	-$30M
Acquisitions (Net)	-$10M
Purchases of Investments	-$34M
Sales/Maturities of Investments	$60M
Other Investing Activities	-$404.0K
NET CASH FROM INVESTING	-$14M
Net Debt Issuance	$13M
Common Stock Repurchased	$0
Common Dividends Paid	-$19M
Other Financing Activities	$0
NET CASH FROM FINANCING	-$4M
FREE CASH FLOW	$17M
Net Change in Cash	$28M

Balance Sheet

Item	Amount
Cash & Equivalents	$58M
Short-Term Investments	$24M
Net Receivables	$159M
Inventory	$198M
Other Current Assets	$27M
TOTAL CURRENT ASSETS	$466M
PP&E (Net)	$140M
Goodwill	$27M
Intangible Assets	$47M
Long-Term Investments	$10M
Tax Assets	$17M
Other Non-Current Assets	$19M
TOTAL NON-CURRENT ASSETS	$261M
TOTAL ASSETS	$727M
Account Payables	$73M
Short-Term Debt	$13M
Deferred Revenue	$0
Other Current Liabilities	$44M
TOTAL CURRENT LIABILITIES	$154M
Long-Term Debt	$314M
Deferred Revenue NC	$0
Deferred Tax Liabilities	$9M
Other Non-Current Liabilities	$34M
TOTAL NON-CURRENT LIABILITIES	$356M
TOTAL LIABILITIES	$511M
Common Stock	$4.0K
Additional Paid-In Capital	$133M
Retained Earnings	$169M
Treasury Stock	$0
Accum. Other Comp. Income	-$86M
Other Equity	$0
TOTAL STOCKHOLDERS' EQUITY	$216M
Minority Interest	$0
TOTAL EQUITY	$216M
TOTAL LIABILITIES & EQUITY	$727M
Total Debt	$326M
Net Debt	$269M